These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 3465583

  • 1. A comparison of the efficacy of high dose and normal dose budesonide in prednisone dependent patients with chronic obstructive lung disease (COLD).
    Overbeek SE, Hilvering C, Bogaard JM, Birkenhäger JC, Neijens HJ.
    Eur J Respir Dis Suppl; 1986; 146():581-4. PubMed ID: 3465583
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of inhaled budesonide on severe steroid-dependent asthma.
    Tukiainen P, Lahdensuo A.
    Eur J Respir Dis; 1987 Apr; 70(4):239-44. PubMed ID: 3556202
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Personal observations on the use of inhaled corticosteroid drugs for chronic asthma.
    Toogood JH, Jennings B, Baskerville J, Lefcoe NM.
    Eur J Respir Dis; 1984 Jul; 65(5):321-38. PubMed ID: 6378649
    [Abstract] [Full Text] [Related]

  • 6. [Corticosteroids as induction treatment of patients with chronic obstructive lung disease].
    Evald T, Hansen M.
    Ugeskr Laeger; 1987 Oct 12; 149(42):2867-9. PubMed ID: 3433460
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease.
    Morice AH, Morris D, Lawson-Matthew P.
    Clin Pharmacol Ther; 1996 Dec 12; 60(6):675-8. PubMed ID: 8988070
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of active Crohn's disease with an oral slow-release budesonide formulation.
    Roth M, Gross V, Schölmerich J, Ueberschaer B, Ewe K.
    Am J Gastroenterol; 1993 Jun 12; 88(6):968-9. PubMed ID: 8503403
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.
    Gross V, Andus T, Caesar I, Bischoff SC, Lochs H, Tromm A, Schulz HJ, Bär U, Weber A, Gierend M, Ewe K, Schölmerich J.
    Eur J Gastroenterol Hepatol; 1996 Sep 12; 8(9):905-9. PubMed ID: 8889459
    [Abstract] [Full Text] [Related]

  • 12. Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.
    Piquet J, Zuck P, Dennewald G, Dugue P, Grivaux M, Brun P, Severac JC, Ostinelli J, Cheeseman KH.
    Adv Ther; 1996 Sep 12; 13(1):38-50. PubMed ID: 10172710
    [Abstract] [Full Text] [Related]

  • 13. Deflazacort in thrombocytopenia: a comparison with prednisone.
    Mazzucconi MG, Malagnino F, De Laurentis C, Criscuolo D.
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec 12; 18(12):538-42. PubMed ID: 7194867
    [Abstract] [Full Text] [Related]

  • 14. Effects of inhaled nebulized steroids (budesonide) on acute and chronic lung function in heart-lung transplant patients.
    Takao M, Higenbottam TW, Audley T, Otulana BA, Wallwork J.
    Transplant Proc; 1995 Feb 12; 27(1):1284-5. PubMed ID: 7878883
    [No Abstract] [Full Text] [Related]

  • 15. Comparison between inhaled and oral corticosteroids in patients with chronic asthma.
    Rosenhall L, Lundqvist G, Adelroth E, Glennow C.
    Eur J Respir Dis Suppl; 1982 Feb 12; 122():154-62. PubMed ID: 6958480
    [Abstract] [Full Text] [Related]

  • 16. Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study.
    Novacek G, Kleinberger M, Vogelsang H, Moser G, Lochs H.
    Z Gastroenterol; 1995 May 12; 33(5):251-4. PubMed ID: 7610692
    [Abstract] [Full Text] [Related]

  • 17. The efficacy of inhaled corticosteroids in the management of non asthmatic chronic airflow obstruction.
    Boothman-Burrell D, Delany SG, Flannery EM, Hancox RJ, Taylor DR.
    N Z Med J; 1997 Oct 10; 110(1053):370-3. PubMed ID: 9364183
    [Abstract] [Full Text] [Related]

  • 18. [The effect of the Russian inhalant glucocorticosteroid budesonide on bronchial inflammation and hyperreactivity during the long-term treatment of bronchial asthma patients].
    Sutochnikova OA, Samsonova MV, Cherniak AV, Cherniaev AL, Sokolov AS, Chuchalin AG.
    Ter Arkh; 1996 Oct 10; 68(3):48-50. PubMed ID: 8744104
    [Abstract] [Full Text] [Related]

  • 19. [Clinical evaluation of budesonide forte action in patients with atopic bronchial asthma].
    Górski P, Pałczyński C.
    Pol Tyg Lek; 1996 Oct 10; 48(7-8):190-2. PubMed ID: 8415265
    [Abstract] [Full Text] [Related]

  • 20. Inhaled budesonide for maintenance treatment of pulmonary sarcoidosis.
    Selroos O, Löfroos AB, Pietinalho A, Niemistö M, Riska H.
    Sarcoidosis; 1994 Sep 10; 11(2):126-31. PubMed ID: 7809497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.